Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. NVDA
4. USO
5. SPCX
6. CRM
7. MH
8. RKLB
9. NDAQ
10. COGT

Go back to Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update

Lexicon Pharma (LXRX) Reports In-Line Q4 EPS

May 5, 2022 6:25 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $37 thousand versus the consensus estimate of $50 thousand.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More